Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...

Tocilizumab and rituximab reduce relapse rates and disability progression in NMOSD, with tocilizumab provides extra benefits in MOGAD.

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...

Complex housing offers varied stimulating conditions. The aim is to enhance cognitive and physical development, as well as overall wellbeing and social interaction benefits.

One of the best ways to maximize absorption is through proper gut health. Before trying supplements, it's important that you ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Broadening access to cladribine should help more patients avoid hospital and free up clinic time.

A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting thousands of patients in England. The move will also “significantly free up ...

COVID-19 affects hundreds of millions of people worldwide and is often associated with long-term neurological abnormalities.

In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain ...

Hyaluronidase naturally degrades hyaluronic acid, leading to issues with cells that produce myelin (the protective sheath ...